ReviewCureus2022

Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer.

Lisbeth Escudero Mendez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.